News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Roche (RHHBY) and AREVA Med LLC Join Forces in the Fight Against Cancer and Create a Novel Radio-Immunotherapy


7/27/2012 9:27:10 AM

BASEL, Switzerland, PARIS and BETHESDA, Md., July 27, 2012 (GLOBE NEWSWIRE) -- Roche (SIX:RO; ROG) (OTCQX:RHHBY) and AREVA Med, a subsidiary of AREVA, announced today that they have entered into a strategic collaboration to create a novel, advanced alpha radio-immunotherapy platform to target and kill cancer cells. The agreement will focus on malignant disease with a high unmet medical need.

Read at GlobeNewswire

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES